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RESUMO 
 
Objetivo: O papel do lipopolissacarídeo bacteriano (LPS) para desencadear a 
inflamação periodontal é bem conhecido. No entanto, o efeito do LPS na modulação 
do estado de metilação do DNA não está completamente claro. Aqui, investigamos o 
efeito do LPS de P. gingivalis no perfil de metilação da região reguladora dos genes 
SOCS1, P16 e TIMP2 em fibroblastos gengivais humanos cultivados, a fim de avaliar 
se o LPS pode alterar o estado de metilação desses genes. Material e Métodos: As 
células de fibroblastos gengivais humanos imortalizadas foram cultivadas em meio 
suplementado com LPS de P. gingivalis ou com o veículo do LPS de P. gingivalis 
durante 12, 24 e 48 horas. A seguir, a viabilidade celular foi avaliada por teste de MTT. 
O DNA genômico foi isolado e convertido por bissulfito de sódio. O estado de 
metilação da região reguladora dos genes P16, SOCS1 e TIMP2 foi analisado por 
PCR específica de metilação seguida por análise de melting de alta resolução (MS-
HRM). Resultados: Tanto fibroblastos estimulados por LPS quanto os fibroblastos 
tratados apenas com o veículo do LPS não mostraram diferenças significativas na 
região analisada dos genes P16, SOCS1 e TIMP2 durante os períodos de 12, 24 e 48 
horas. Conclusão: Pequenos períodos de estimulação com LPS não foram suficientes 
para promover alterações de metilação nas regiões analisadas dos genes SOCS1, 
P16 e TIMP2 em fibroblastos. Relevância clínica: Compreender o papel das moléculas 
derivadas de periodontopatógenos na promoção de alterações de metilação dentro da 
região reguladora de genes-chaves associados à periodontite é importante para 
aumentar o reconhecimento da área e pode abrir portas para o desenvolvimento de 
novas terapias adjuvantes. 
  
Palavras-chave: Epigenética, metilação do DNA, lipopolissacarídeo, LPS, 
fibroblasto, MS-HRM 
 
  
ABSTRACT 
 
Objective: The role of bacterial lipopolysaccharide (LPS) to trigger periodontal 
inflammation is well known. However, the effect of LPS in modulating the methylation 
status of DNA is not completely clear. Here, we investigated the effect of P. gingivalis 
LPS on the methylation profile of regulatory region of SOCS1, P16 and TIMP2 genes 
in cultured human gingival fibroblast in order to assess whether LPS can alter the 
methylation status of these genes. Material and Methods: Immortalized human gingival 
fibroblast cells were cultured in medium supplemented with P. gingivalis LPS or P. 
gingivalis LPS vehicle during 12, 24 and 48 hours. Following, cell viability was 
assessed by MTT test. Genomic DNA was isolated and converted by sodium bisulfite. 
The methylation status of the regulatory region of P16, SOCS1 and TIMP2 genes was 
analyzed by methylation specific PCR followed by high resolution melting analysis 
(MS-HRM). Results: Either fibroblast LPS-stimulated or fibroblast treated only with 
vehicle did not show significant differences in the analyzed region of P16, SOCS1 and 
TIMP2 genes during the periods of 12, 24 and 48 hours. Conclusion: Short periods of 
LPS stimulation were not enough to promote methylation changes in the analyzed 
regions of SOCS1, P16 and TIMP2 genes in fibroblasts. Clinical Relevance: 
Understanding the role of molecules derived from periodontopathogens in promoting 
methylation changes within regulatory region of key genes associated with 
periodontitis is important to increase the area acknowledgment and can open doors to 
the development of new adjuvant therapies.  
  
Key words: Epigenetics, DNA methylation, lipopolysaccharide, LPS, fibroblast, MS-
HRM  
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1 INTRODUÇÃO 
A periodontite (ou doença periodontal) é uma desordem inflamatória que 
afeta os tecidos de suporte dos dentes (periodonto) e que da fase aguda torna-se 
crônica. Está claro que o acúmulo de bactérias sobre a superfície da região cervical 
dos dentes desencadeia a doença, porém seu agravamento e severidade são 
dependentes de fatores como o hábito de fumar, a genética do hospedeiro e a 
condição de saúde sistêmica.  
A composição genética e epigenética do hospedeiro também podem 
modular o prognóstico da doença periodontal. A epigenética pode ser definida como 
mudanças no padrão de expressão do gene não envolvendo a sequência do DNA 
(Larsson et al., 2015). A metilação do DNA e modificações em histonas são as duas 
principais alterações epigenéticas em humanos (Takai et al., 2015). Essas alterações 
podem contribuir para o desenvolvimento e manutenção de doenças inflamatórias, 
doenças autoimunes e do câncer (Larsson et al., 2015). A metilação do DNA é um 
mecanismo epigenético primário caracterizado pela adição de um grupo metil em 
citosinas precedidas de guanina em regiões nomeadas ilhas CpG. As ilhas CpG 
(CGIs) são pequenas sequências intercaladas de DNA que desviam significantemente 
da média do padrão genômico por serem ricas em GC e são predominantemente não-
metiladas. As ilhas CpG evidentemente contém sítios de ínicio de transcrição (TSS), 
os quais coincidem com a região promotora dos genes em ratos e humanos. As 
características das sequências de DNA partilhadas adaptaram as CGIs para a função 
de regiões promotoras, desestabilizando nucleossomos e atraindo proteínas que 
criam um estado de cromatina transcricionalmente permissivo (Deaton e Bird, 2011). 
A metilação do DNA está associada à várias mudanças na estrutura da 
cromatina e ao recrutamento de proteínas para os sítios metilados. A metilação 
geralmente leva à obstrução da região promotora, dificultando a transcrição gênica e 
subsequentemente causando o silenciamento do gene (Rettori et al., 2013). A 
metilação é mediada pelas enzimas da família das DNA metiltransferases (DNMTs), 
sendo a função principal da DNMT1 a manutenção da metilação, metilando sítios 
hemimetilados gerados durante a replicação do DNA, e as enzimas de novo DNMT3a 
e DNMT3b são responsáveis pela metilação do DNA durante o desenvolvimento 
embrionário (Abiko et al., 2014).  Infecções bacterianas também induzem 
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modificações epigenéticas em células humanas, e a hipermetilação do DNA tem sido 
implicada na doença periodontal em humanos (Larsson et al., 2015). 
Patógenos periodontais são fatores ambientais cruciais no 
desenvolvimento da doença periodontal. Uma bactéria que é frequentemente 
detectada em bolsas periodontais é a Porphyromonas gingivalis. P. gingivalis é uma 
bactéria anaeróbica, gram-negativa, que possui muitos fatores de virulência como 
enzimas proteolíticas, fímbrias e lipopolissacarídeos (LPS) (Palm et. al., 2015). O LPS 
é utilizado como uma toxina bacteriana para provocar respostas agudas em modelos 
experimentais de infecção (Ding e Jin, 2014) (Johansson et al., 1996).  
Fibroblastos gengivais são o tipo mais comum de células encontradas no 
tecido gengival. Além de fornecerem uma estrutura tecidual, os fibroblastos também 
demonstram responderem aos patógenos associados a padrões moleculares 
(PAMPs) via, por exemplo, receptores ativados por proteases (PARs) e receptores do 
tipo toll (TLRs), sendo o TLR2 e o TLR4 (Palm et al., 2015). Além de manter a 
integridade do tecido gengival por meio da regulação do metabolismo do colágeno e 
dos proteoglicanos, os fibroblastos gengivais produzem várias citocinas pró-
inflamatórias, como a interleucina-1 (IL-1), IL-6 e IL-8 em resposta à estimulação direta 
e indireta com LPS (Tabeta et al., 2000). Fibroblastos do ligamento periodontal de 
humanos estimulados por um longo período por LPS apresentaram hipermetilação de 
genes da matriz extracelular, e as metilações ocorridas nas regiões promotoras dos 
genes FANK1, COL4A1-A2, 12A1 e 15A1, LAMA5 e B1, MMP25, POMT1 e EMILIN3 
estavam relacionadas com o baixo nível de expressão transcricional desses genes 
(Takai et al., 2015). 
O estudo da epigenética, especialmente a metilação do DNA, oferece um 
enorme potencial para a identificação de marcadores biológicos que podem ser 
utilizados no diagnóstico dos primeiros estágios de desenvolvimento do câncer, e para 
uma avaliação mais precisa do risco individual de desenvolver doenças (Calmon et al, 
2007). A proliferação celular é regulada em parte pelo produto proteico do gene 
supressor de tumor P16 (Cody et al, 1999). Tipicamente, p16 induz a parada do ciclo 
celular e impede a divisão celular através da inibição das quinases dependentes de 
ciclina CDK4 e CDK6, bem como a fosforilação mediada por CDK do gene do 
retinoblastoma (Conceição et al, 2015). O gene P16 foi um dos primeiros genes 
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investigados em câncer de cabeça e pescoço associado com a metilação do promotor 
do gene, e é amplamente investigado em câncer oral (Ha e Califano, 2006). 
As metaloproteinases da matriz (MMPs) são consideradas enzimas de 
grande importância na destruição do tecido conjuntivo. Essas enzimas eventualmente 
degradam o ligamento periodontal e as proteínas da matriz óssea. Inibidores teciduais 
das metaloproteinases da matriz (TIMPs) são inibidores específicos das MMPs, e 
desempenham um papel relevante no metabolismo da matriz extracelular periodontal 
através do controle da atividade das MMPs (Kubota et al., 2008). O inibidor tecidual 
de metaloproteinases-2 (TIMP2) é conhecido por antagonizar a atividade das 
metaloproteinases da matriz e suprimir o crescimento tumoral, angiogênese, invasão 
e metástases (Parashar e Capalash, 2012). Um desequilíbrio na interação MMP-TIMP 
está implicado na etiologia da doença periodontal, onde a degradação da matriz 
extracelular é uma característica principal (de Souza et al., 2005).  
Muitas citocinas pró-inflamatórias desempenham papéis fundamentais na 
iniciação de vias de sinalização intracelular específicas. Umas das mais importantes 
cascatas de sinalização induzidas por citocinas é a via JAK/STAT (JAK (Janus kinase) 
/ STAT (Signal Transducer e Activator of Transcription) (Andia et al., 2015). Os 
supressores de sinalização de citocinas (SOCS) são uma família de proteínas 
intracelulares que participam da regulação da resposta de células imunes ao estímulo 
de várias citocinas pró-inflamatórias. SOCS1 é um potente inibidor de sinalização de 
citocinas (Andia et al., 2015). A metilação do DNA é um importante mecanismo que 
controla os níveis de transcrição do gene SOCS1. A Ilha CpG do gene SOCS1 invade 
a região do primeiro e segundo éxon (De Souza et al., 2014). A hipermetilação do 
gene SOCS1 é capaz de controlar a expressão de outros genes através da interação 
enhancer/promotor, e este evento tem grande importância na patogênese da 
inflamação crônica (Planello, 2014). 
O presente estudo teve como objetivo analisar por MS-HRM (Methylation 
Sensitive High Resolution Melting) a porcentagem da metilação dos genes P16, 
SOCS1 e TIMP2 em cultura de fibroblastos gengivais humanos expostos ao LPS no 
período de 12 horas, 24 horas e 48 horas. 
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ABSTRACT 
Objective: The role of bacterial lipopolysaccharide (LPS) in triggering periodontal inflammation 
is well known. However, the effect of LPS in modulating the methylation status of DNA is not 
completely clear. Here, we investigated the effect of P. gingivalis LPS on the methylation profile 
of regulatory region of SOCS1, P16 and TIMP2 genes in cultured human gingival fibroblast in 
order to assess whether LPS can alter the methylation status of these genes. 
Material and Methods: Immortalized human gingival fibroblast cells were cultured in medium 
supplemented with P. gingivalis LPS or P. gingivalis LPS vehicle during 12, 24 and 48 hours. 
Following, cell viability was assessed by MTT test. Genomic DNA was isolated and converted 
by sodium bisulfite. The methylation status of the regulatory region of P16, SOCS1 and TIMP2 
genes was analyzed by Methylation-Sensitive High Resolution Melting  (MS-HRM). 
Results: Neither fibroblast LPS-stimulated nor fibroblast treated only with vehicle showed 
significant differences in the analyzed region of P16, SOCS1 and TIMP2 genes during the 
periods of 12, 24 and 48 hours of treatment. 
Conclusion: Short periods of LPS stimulation were not enough to promote methylation changes 
in the analyzed regions of SOCS1, P16 and TIMP2 genes in fibroblasts. 
Clinical Relevance: Understanding the role of molecules derived from periodontopathogens in 
promoting methylation changes within regulatory region of key genes associated with 
periodontitis is important to increase the area acknowledgment - opening doors to the 
development of new adjuvant therapies.  
 
  
Key words: Epigenetics, DNA methylation, lipopolysaccharide, LPS, fibroblast, MS-HRM 
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INTRODUCTION 
Periodontitis represents the most important oral disease of industrialized countries, 
responsible for teeth-lost in more than 20% of adult population [1]. It is an infection-associated 
inflammation disease induced by bacteria-derived molecules, such as lipopolysaccharide 
(LPS), that promotes the collagen type I breakdown and its solubilization from soft and hard 
periodontal tissues [2, 3].  
In the last decades, explosion of studies have focused on the molecular basis of 
periodontitis in order to find the pathways that regulate the host tissues destruction. The 
understanding of how signal factors, cytokines, growth factors and transcriptional factors act 
during periodontitis have raised the knowledge of area. However, the investigation of factors 
directly associated with gene function is essential to clarify the real mechanisms.  
Addressed to this topic, epigenetic emerges as the field committed to investigate the 
genome regulation. Epigenetic is the study of DNA/histone chemical changes inherited after 
mitotically and meiotically cell divisions that control chromatin structure and, consequently, 
gene functions [4,5]. Several proteins and enzymes take part in the molecular basis of 
epigenetics that involves histones modifications, noncoding RNAs and DNA methylation. 
Surely, DNA methylation does represent the most studied epigenetic change in the human 
genome that is carried out by DNA methyltransferases (DNMTs): the maintenance 
methyltransferase DNMT1 and de novo methyltransferases DNMT3A and DNMT3B. CpG 
enriched regions (named as CpG islands) are not randomly distributed around the whole 
genome and tends to be concentrated within regulatory regions such as gene promoters [6]. 
Ordinarily, CpG islands are found unmethylated but can become methylated during diseases, 
especially during tumor development and chronic inflammation.  
We have reported that LPS can modify the transcription level of some chromatin 
modifying enzymes in human keratinocytes cells [7]. Adding, a few studies have shown that 
LPS-stimulated cells can answer differentially to epigenetic drugs [8] as well as extracellular 
matrix-related genes can become hypermethylated in human periodontal fibroblasts stimulated 
for a prolonged period with LPS derived from P. gingivalis [9].  
 Therefore, in the present paper we hypothesized whether LPS derived from P. 
gingivalis could be able to promote DNA methylation changes in the regulatory region of three 
genes that contain CpG islands and are implicated in different cell functions: SOCS1 a member 
of Suppressor Of Cytokine Signaling family that acts as classic negative feedback inhibitors of 
JAK/STAT pathway and is key physiological regulator of both innate and adaptive immunity 
[10]; P16 (also known as P16INK4a or CDKN2A) a tumor suppressor gene implicated in the 
prevention of several cancers, including oropharyngeal squamous cell carcinoma, cervical 
cancer, esophageal cancer [11], considered a key factor in controlling the G1 phase of cell 
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cycle; and TIMP2 (Tissue Inhibitor of Metalloproteinases-2) a member of TIMP family 
responsible for the physiological inhibition of matrix metalloproteinases (MMPs), whose 
imbalance can lead to connective tissue destruction [12]. Our analysis were carried on human 
gingival fibroblasts and MS-HRM assay was performed in order to quantify the percentage of 
DNA methylation in LPS-stimulated and non-stimulated cells. 
 
 
MATERIAL AND METHODS 
Materials  
DMEM medium (Dulbecco’s Modified Eagle’s medium, Sigma Chemical Co.) was obtained 
from Cultilab (São Paulo, Brazil). Heat-inactivated fetal bovine serum (FBS) and trypsin/ 
ethylenediamine tetraacetic acid (EDTA) solution used in all experiments were purchased from 
LGC Biotecnologia (São Paulo, Brazil). The antibiotics (penicillin/streptomycin/) were 
purchased from GIBCO (Grand Island, NY, USA). Tissue culture multiwell plates were 
obtained from TPP® (Switzerland). P. gingivalis lipopolysaccharide (P. gingivalis LPS), 
extracted from P. gingivalis strain ATCC 3327, was obtained from InvivoGen (cat. code: tlrl-
pglps, San Diego, CA, USA). For the viability analysis, a MTT assay was purchased from 
Invitrogen, Thermo Fisher Scientific. Quick-DNA Universal kit was obtained from Zymo 
Research. MethyISEQr Bisulfite Conversion kit was purchased from Life (Carlsbad, CA, USA). 
LightCycler®480 HRM Master Mix was purchased from Roche (Mannheim, Germany). EpiTect 
PCR Control DNA Set was obtained from Qiagen.  
 
Cell Culture and LPS Treatment 
Immortalized human gingival fibroblast cell line (HGF-1, ATCC® CRL-201) were cultured in 
DMEM medium supplemented with 10% FBS (fetal bovine serum) and 1% antibiotics in the 
humidified atmosphere (5% CO2) at 37oC with subculture every 3 days. At harvest, the cells 
were plated at a concentration of 1x105/mL and were exposed to P. gingivalis LPS at 
concentration of 1g/mL in serum re-supplemented with 10% FCS. The experiments were 
carried on at 12, 24 and 48 hours and after each 24 hour new amount of DMEM medium 
containing 10% FBS and LPS (1g/mL) was replaced. Culture treated with LPS vehicle 
(deionized water used to dilute LPS) was used as control. The experiment was performed in 
triplicate. 
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Viability Cell Assay 
Cell viability was assessed by MTT reduction to formazan crystals by mitochondrial enzyme 
reductases using a MTT biochemical assay in 96-well plates. 1x105 cells/mL were seeded in 
wells and the assay was carried on in triplicate for each experimental time. MTT assay was 
performed following the manufacturer ś protocol (Invitrogen). Finally, the multiwell plate was 
mixed until complete salt crystal dissolution and absorbance was measured in an ELISA reader 
(Molecular Devices, CA, USA) using the software VersaMax (test wavelength 570 nm, 
reference wavelength 630 nm).  
 
DNA Extraction and Bisulfite Treatment  
DNA was purified using Quick-DNA Universal kit, according to the manufacturer ́s protocol. 
After, 0.5 g of gDNA was bisulfite converted by MethyISEQr Bisulfite Conversion kit, following 
the manufacturer ś protocol. The samples were short time storage at 04C and used for MS-
HRM.  
 
Methylation Sensitive High Resolution Melting (MS-HRM)  
Real-time PCR followed by HRM was carried out in Light Cycler 480 II (Roche, Mannheim, 
Germany). The sequence of the primer set used is shown in Table 1. The reaction mixture 
consisted of 18 ng of bisulfite-converted DNA, 1x LightCycler®480 HRM Master Mix, 150 nM 
of each primer, 3 mM of MgCl+2 in a final volume of 20 μl. The reaction conditions were 
performed in a equal start for all genes at 95°C for 10 minutes, followed by specific cycles for 
each gene: P16 – 45 cycles at 95°C for 10 seconds, 64°C for 10 seconds, 72 °C for 10 
seconds; TIMP2 – 45 cycles at 95°C for 10 seconds, 59°C for 05 seconds, 72 °C for 10 
seconds; SOCS1 – 45 cycles at 95°C for 10 seconds, 55°C for 04 seconds, 72 °C for 10 
seconds. MS-HRM analyses were performed at the temperature ramping and fluorescence 
acquisition settings recommended by the manufacturer, 1 minute at 95 °C, a hold at 70 °C for 
1 minute to allow re-anneling of all PCR product, then the acquisition step started ramping from 
70 °C to 95 °C, rising by 0,2 °C/s with 25 acquisitions per °C.  
To estimate the methylation level of the samples, converted fully methylated and fully 
unmethylated DNA (EpiTect PCR Control DNA Set) were used to prepare dilution series as 
controls. The dilution series of relevant methylated DNA in a background of unmethylated DNA 
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were prepare in the concentration of 0%, 5%, 10%, 25%, 50% and 100% of methylation to 
build standards curves. PCR bias toward unmethylated DNA was reversed following the 
guideline published by Wojdacz (22). Standard curves and no template controls were included 
in each experimental run. As a negative control, genomic unconverted DNA was tested once 
with each primer. Initial assays were first run using 50% and 0% controls until the 
proportionality of amplification was achieved. MS-HRM data were normalized with the Light 
Cycler 480 II analysis software to compensate for varying starting fluorescence levels. The 
amplicon melting profile of each sample was compared to standard curves, and based on that, 
samples of each individual was classified into different methylation categories; 0-5, 6-10, 11- 
25, 26-50 and 51-100%. The experiment was performed in triplicate. 
 
 
RESULTS 
MTT assay showed no effect of LPS on HGF cells viability at concentration of 1g/mL as well 
this LPS concentration did not alter the morphology of cells when we observed them by 
microscopy (Figure 1). 
Following, human gingival fibroblasts were treated with P. gingivalis LPS in order to 
analyze the potential of this molecule derived from bacteria in promoting methylation changes 
in the regulatory region of P16, TIMP2 and SOCS1 genes. The assays were performed using 
MS-HRM approach in order to quantify methylation changes in those genes. Either exposure 
of HGF cells to LPS for 12h, 24h or for 48h did not promote significant differences in the 
methylation profile of the analyzed regions of these genes. The MS-HRM results of P16, TIMP2 
and SOCS1 genes are shown in Figure 2, 3 and 4, respectively.  
 
 
DISCUSSION 
Cell functions such as activation, proliferation, and survival are differently controlled during 
chronic inflammation. It occurs not only due the number of new cascades of signal transduction 
pathways installed during inflammation, that activate different transcriptions factors that take 
part in the immune-inflammatory response, but also due the chromatin-remodeling that allows 
or prohibits the access of transcription factors to different regions of genome [13,14].  
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 LPS is a component of the cell wall of gram-negative bacteria responsible for inducing 
expression of a range of pro-inflammatory cytokines such as TNF-α, IL-1β and IL-6 [15]. 
Injection of sub-lethal doses of LPS into animals demonstrated that a state of “LPS tolerance” 
was induced in the animals [16]. Interesting, while some genes became unable to answer to 
LPS-stimulation another group of genes entitled “non-tolerizable” escape from the suppressive 
effect of LPS tolerance [15]. Addressed to it, studies have demonstrated that gene promoters 
can be regulated in order to confer their tolerized status and apparently, the mechanism 
associated to it is chromatin-remodeling. Histone-modifications are found associated with LPS 
stimulation. Different histone marks are found as consequence of LPS stimulation and 
depending on if acute or whether prolonged (chronic) stimulation, these marks are different 
and induce an open or compacted chromatin status.  For example, upon an acute LPS 
stimulation, H3K9 unmethylated is found in naïve human monocytes, while H3K9 dimethylation 
is observed in the same but tolerized cells [17, 18, 19].  
In addition to histone modifications, DNA methylation is other epigenetic event able to 
regulate gene expression and confers gene tolerance to LPS. Unfortunately, DNA methylation 
was not widely investigated in acquire LPS-tolerance until moment, but is hypothesized that 
DNA methylation could be the final step in the tolerization process [15]. Recently, we published 
a study reporting that short period of LPS stimulation modulates gene expression of some 
enzymes implicate with epigenetic changes, such as DNA methyltransferases (DNMT1 and 
DNMT3A) [7].  
P. gingivalis is a distinguished gram-negative periodontal pathogen able to lead 
consequences on host cells and LPS is a key bacteria-derived molecule that recognizes and 
binds to toll-like receptors TLR2 and TLR4 to trigger its effects [8]. In this study we challenged 
human gingival fibroblast cells with LPS derived from P. gingivalis in order to assess how short 
period of LPS-stimulation could modify the methylation profile of SOCS1, P16 and TIMP2 
genes that are associated with different cell functions. Performing MS-HRM analysis, it is 
possible to verify percentages changes of methylation within DNA in a scale less than 1%. 
SOCS family is composed by eight members that share similar structure. However, 
only SOCS1 and SOCS3 contain in the N-terminus sequence of 12-amino acids capable to 
inhibit the kinase activity of JAK2, due the presence of a pseudo-substrate for JAK2 in this 
additional region. Transcription of SOCS1 can be induced by cytokines that trigger JAK-STAT 
signaling pathway. Although gene promoter of SOCS1 shows motif to STAT-binding, the 
expression of SOCS1 leads the inhibition of JAK-STAT signaling via down-regulation of STAT 
activation due the blockage of kinase activity by the pseudo-substrate present in SOCS1.  
Reports have suggested that SOCS1 down-regulates the TLR signaling via LPS sensitivity 
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modulation. SOCS1-/- and INF-γ-/- mice showed an increased response to LPS when compared 
to only INF-γ-/- mice. Added, SOCS1-/- macrophages were hyper-responsive to LPS, indicating 
that SOCS1 can play a key role in the regulation of TLR via LPS signaling [20].  
The analysis of SOCS1 genes did not shown any methylation changes in DNA when a 
short period of LPS-stimulation was assayed. Epigenetic changes in the intragenic region of 
SOCS1 have been frequently associated with chronic inflammation [21]. SOCS1 is a small 
gene that contains a CpG island (CGI) inside the promoter region that overlaps the first and 
second exons. This CGI is frequently observed hypermethylated in chronic disease as hepatitis 
and some types of cancer, taking part in the CGI methylator phenotype (CIMP) panel in colon 
cancer. Positive correlation between presence of methylation in regulatory region of SOCS1 
and down-regulation of gene transcription is not always found. Recently, we published a paper 
showing that this same region of SOCS1 may act as an enhancer element over other genes 
of chromosome 16 in gingival tissue [21].  
The tumor suppressor gene P16 (P16INK4a) plays a key role in cell cycle regulation by 
decelerating cells progression from G1 phase to S phase. The protein is encoded by the 
CDKN2A locus that is located within human chromosome 9p21. This protein is a member of 
INK4 family of cyclin-dependent kinase inhibitors, mainly known to form a complex with CDK4 
and CDK6 [23].  Although the mainly function of P16 is associated with tumor prevention, other 
different functions have been described for P16 in chronic inflammation. Proliferation of 
synovial fibroblasts is an ordinary event in rheumatoid arthritis trigged by molecules of 
inflammation. The intra-articular gene transfer of P16 was capable to inhibit synovial 
hyperplasia, immune-inflammatory cells infiltration, bone and cartilage joint destruction [24,25]. 
These findings are credit to the ability of P16 in inhibiting CDK4 and CDK6 that are responsible 
to release E2F transcription factors that allow cell-cycle progression [26]. P16 can also 
modulate the pro-inflammatory transcription factors NF-kB and AP-1 via its ankyrin motifs that 
bind c-jun [27] and NF-kB [28] and inhibit their activity. However, this P16 function is not 
available apparently in all cell types. 
P16 gene is frequently mutated or deleted in a variety of cancer types as well as it can 
be silencing by hypermethylation. The P16 gene is found methylated in oral, esophageal and 
lung squamous cell carcinoma, in all of them the hypermethylation suppresses the mRNA 
transcription and, consequently, the protein expression [29]. In this study we tested the thesis 
of P16 gene becomes methylated in fibroblast as a consequence of LPS-stimulation. However, 
the results showed P16 completely unmethylated after LPS-stimulation for a short period.  
TIMP-2 is one of a group of four members that compose the TIMP family, the natural 
tissue inhibitors of matrix metalloproteinases (MMPs). The inhibition is reached by the N-
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terminal region of TIMP proteins that binds to the catalytic domain of MMPs. TIMP-2 
specifically binds to MT1-MMP and this bi-molecular complex takes part in the process of pro-
MMP2 activation [30]. Thus, TIMP-2 represents an inhibitor and activator of MMPs. Although 
TIMP-2 is secreted in the extracellular matrix, having well know functions outside cells, a 
number of reports have suggested a other functions to TIMP proteins since these proteins link 
to membrane receptors of different types of cells [31]. TIMP2 gene transcription is regulated 
epigenetically. CpG island that overlapping TIMP2 gene promoter is commonly seen 
hypermethylated in MCF-7 cells, silencing the gene transcription [31]. We did not detected 
methylation in the TIMP2 gene after LPS-stimulation. However, we emphasize the same could 
not be repeated whether other assay conditions would be performed such as LPS-stimulation 
for long period.  
Previous study reported hypermethylation of extracellular matrix-related genes when 
fibroblasts were induced by LPS-stimulation for a prolonged period [9]. The LPS-stimulation 
period was basically the difference between our study and the other one. These results agree 
with the clinical findings in patients. Gingivitis is an acute inflammation that shows a set of 
clinical signs, microscopic and molecular features completely different from the set of findings 
that are seen in chronic periodontitis. Probably, the long-term exposure to LPS may promote 
epigenetic changes that are not detectable when we performed a short-term assay.  
In conclusion, LPS stimulation did not promote methylation changes in the promoter 
region of SOCS1, P16 and TIMP2 genes when human gingival fibroblasts were stimulated for 
a short period. There is no guarantee the same would be found if others genome regions, 
others genes, others cell types or others assay-periods would be tested. Then, we have an 
“open sea” of hypothesis that must be still assayed in order to increase our knowledge about 
the effects of LPS in promoting epigenetic changes. 
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Table 1: Sequence of MS-HRM primers set, amplicons size and number of CpG sites 
analyzed in the fragments. 
Gene 
 
Primer sequences (CpG sites 
underlined and converted Cs as 
capital Ts or As). (5'→ 3').  
 
 
 
   Amplicon 
 
CpGs between 
the primers set 
 
P16 
F: ggagTTttcggTtgaTtggTtggTT 
R: aAcaAcgcccgcacctcctcta 
 
 
69bp 
 
 
05 
TIMP2 
F: gTaTcggggagTagTtgTagg 
 
R: cgctcgAcctcctActActAA 
 
66bp 
 
06 
 
SOCS1 
F: tcgcggTtgTTatTTaggtgaaag 
 
R: cgaAcccgtAAAcaccttcctA 
 
 
140bp 
 
 
12 
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Figure 1.  The figure represents the % of cells viability after HGF cells exposed to P. 
gingivalis LPS (1g/mL) for 12h, 24h and 48h or only vehicle (deionized water/control) 
at the same periods of time. No significant differences were observed on the HGF cells 
viability after the treatments (n=3/group).   
 
 
 
Figure 2. MS-HRM assay of P16 gene. Different percentages of DNA methylation are 
shown in different color in the curves. The percentages are obtained from the mix of 
methylated and unmethylated control DNAs what allowed to build the assay calibration 
curve. Samples are shown as strong blue color near to 0% (brown lines). The result 
indicates that the promoter of P16 gene is completely unmethylated (0%) in control 
and HGF cells after all periods of LPS treatment.  
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Figure 3. MS-HRM assay of TIMP2 gene. Different percentages of DNA methylation 
are shown in different color in the curves. The percentages are obtained from the mix 
of methylated and unmethylated control DNAs what allowed to build the assay 
calibration curve. Samples are shown as strong blue color near to 0% (blue lines). The 
result indicates that the promoter of TIMP2 gene is completely unmethylated (0%) in 
the control and HGF cells after all periods of LPS treatment.  
 
 
 
Figure 4. MS-HRM assay of SOCS1 gene. Different percentages of DNA methylation 
are shown in different color in the curves. The percentages are obtained from the mix 
of methylated and unmethylated control DNAs what allowed to build the assay 
calibration curve. Samples are shown as strong blue color near to 0% (red lines). The 
result indicates that the promoter of SOCS1 gene is completely unmethylated in the 
control and HGF cells after all periods of LPS treatment.  
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3 CONCLUSÃO 
No presente estudo, nós concluímos que fibroblastos gengivais humanos 
estimulados por LPS em um curto período não apresentaram alterações de metilação 
nos promotores dos genes P16, TIMP2 e SOCS1. Outros períodos de ensaio devem 
ser realizados a fim de verificar se o LPS promoverá alterações na metilação dos 
promotores desses genes, ou em outras regiões desses genes. Portanto, temos 
inúmeras hipóteses que ainda devem ser ensaiadas, a fim de aumentar o nosso 
conhecimento sobre os efeitos do LPS na promoção de alterações epigenéticas. 
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ANEXO 1 – Carta de submissão do periódico Clinical Oral Investigation 
 
 
 
